Structure

Physi-Chem Properties

Molecular Weight:  240.08
Volume:  250.242
LogP:  3.285
LogD:  3.124
LogS:  -3.044
# Rotatable Bonds:  1
TPSA:  49.69
# H-Bond Aceptor:  3
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.805
Synthetic Accessibility Score:  2.573
Fsp3:  0.067
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.692
MDCK Permeability:  2.1667996406904422e-05
Pgp-inhibitor:  0.226
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.111
30% Bioavailability (F30%):  0.022

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.028
Plasma Protein Binding (PPB):  86.01386260986328%
Volume Distribution (VD):  1.39
Pgp-substrate:  13.205477714538574%

ADMET: Metabolism

CYP1A2-inhibitor:  0.983
CYP1A2-substrate:  0.124
CYP2C19-inhibitor:  0.904
CYP2C19-substrate:  0.063
CYP2C9-inhibitor:  0.758
CYP2C9-substrate:  0.918
CYP2D6-inhibitor:  0.907
CYP2D6-substrate:  0.862
CYP3A4-inhibitor:  0.733
CYP3A4-substrate:  0.339

ADMET: Excretion

Clearance (CL):  12.466
Half-life (T1/2):  0.9

ADMET: Toxicity

hERG Blockers:  0.349
Human Hepatotoxicity (H-HT):  0.118
Drug-inuced Liver Injury (DILI):  0.18
AMES Toxicity:  0.409
Rat Oral Acute Toxicity:  0.085
Maximum Recommended Daily Dose:  0.888
Skin Sensitization:  0.892
Carcinogencity:  0.631
Eye Corrosion:  0.003
Eye Irritation:  0.826
Respiratory Toxicity:  0.356

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC74821

Natural Product ID:  NPC74821
Common Name*:   Idronoxil
IUPAC Name:   3-(4-hydroxyphenyl)-2H-chromen-7-ol
Synonyms:   Idronoxil; NV-06
Standard InCHIKey:  ZZUBHVMHNVYXRR-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C15H12O3/c16-13-4-1-10(2-5-13)12-7-11-3-6-14(17)8-15(11)18-9-12/h1-8,16-17H,9H2
SMILES:  c1cc(ccc1C1=Cc2ccc(cc2OC1)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1957038
PubChem CID:   219100
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0004154] Hydroxyisoflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24045 Lespedeza homoloba Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO24045 Lespedeza homoloba Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO24045 Lespedeza homoloba Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT3031 Individual Protein Estrogen receptor alpha Rattus norvegicus IC50 = 660.69 nM PMID[527982]
NPT171 Cell Line MRC5 Homo sapiens GI50 = 109000.0 nM PMID[527983]
NPT82 Cell Line MDA-MB-231 Homo sapiens GI50 = 62900.0 nM PMID[527983]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 = 33000.0 nM PMID[527986]
NPT82 Cell Line MDA-MB-231 Homo sapiens GI50 = 31300.0 nM PMID[527987]
NPT171 Cell Line MRC5 Homo sapiens IC50 = 108500.0 nM PMID[527987]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 54.0 % PMID[527983]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 18.0 % PMID[527983]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 80.0 % PMID[527983]
NPT27 Others Unspecified RatioGI50 = 13.6 n.a. PMID[527983]
NPT27 Others Unspecified RatioGI50 = 1.7 n.a. PMID[527983]
NPT27 Others Unspecified RatioGI50 = 26.4 n.a. PMID[527983]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 8000.0 nM PMID[527983]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 4100.0 nM PMID[527983]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Potency n.a. 16774.4 nM PMID[527984]
NPT35 Others n.a. LogD7.4 n.a. 3.8 n.a. PMID[527985]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 9900.0 nM PMID[527986]
NPT2 Others Unspecified GI50 = 4500.0 nM PMID[527987]
NPT2 Others Unspecified Selectivity ratio = 3.5 n.a. PMID[527987]
NPT2 Others Unspecified Selectivity ratio = 24.1 n.a. PMID[527987]
NPT2 Others Unspecified GI50 > 100000.0 nM PMID[527987]
NPT2 Others Unspecified Selectivity ratio < 1.0 n.a. PMID[527987]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC74821 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.991 High Similarity NPC295259
0.9646 High Similarity NPC258979
0.9646 High Similarity NPC8283
0.9646 High Similarity NPC93398
0.9478 High Similarity NPC54972
0.9478 High Similarity NPC193364
0.9397 High Similarity NPC100099
0.9397 High Similarity NPC36016
0.9316 High Similarity NPC76465
0.9316 High Similarity NPC38761
0.9237 High Similarity NPC197351
0.9237 High Similarity NPC106914
0.9237 High Similarity NPC86502
0.9237 High Similarity NPC246648
0.9237 High Similarity NPC134195
0.9204 High Similarity NPC185541
0.9204 High Similarity NPC464
0.9167 High Similarity NPC149796
0.916 High Similarity NPC167571
0.916 High Similarity NPC188022
0.916 High Similarity NPC17809
0.916 High Similarity NPC285040
0.916 High Similarity NPC278552
0.916 High Similarity NPC102540
0.916 High Similarity NPC103420
0.916 High Similarity NPC207179
0.9145 High Similarity NPC97432
0.9145 High Similarity NPC190454
0.9123 High Similarity NPC85292
0.9123 High Similarity NPC54507
0.9123 High Similarity NPC229147
0.9083 High Similarity NPC26879
0.9083 High Similarity NPC283049
0.9083 High Similarity NPC276212
0.9083 High Similarity NPC471215
0.9083 High Similarity NPC262573
0.9083 High Similarity NPC50315
0.9083 High Similarity NPC230479
0.9076 High Similarity NPC270030
0.9016 High Similarity NPC134360
0.9 High Similarity NPC168259
0.8966 High Similarity NPC131118
0.8957 High Similarity NPC203113
0.8943 High Similarity NPC91291
0.8934 High Similarity NPC222572
0.8934 High Similarity NPC39064
0.8934 High Similarity NPC47283
0.8934 High Similarity NPC87224
0.8934 High Similarity NPC38664
0.8934 High Similarity NPC274717
0.8934 High Similarity NPC53986
0.8929 High Similarity NPC106141
0.8917 High Similarity NPC159132
0.8889 High Similarity NPC172253
0.8889 High Similarity NPC59561
0.8871 High Similarity NPC164804
0.8871 High Similarity NPC118683
0.8871 High Similarity NPC211413
0.8871 High Similarity NPC293203
0.8871 High Similarity NPC244888
0.8871 High Similarity NPC68205
0.8862 High Similarity NPC93962
0.8852 High Similarity NPC46978
0.8824 High Similarity NPC52247
0.8793 High Similarity NPC141090
0.8793 High Similarity NPC150624
0.8772 High Similarity NPC280606
0.875 High Similarity NPC74137
0.8739 High Similarity NPC102639
0.873 High Similarity NPC168059
0.873 High Similarity NPC77196
0.873 High Similarity NPC229442
0.873 High Similarity NPC92805
0.872 High Similarity NPC150011
0.872 High Similarity NPC118114
0.872 High Similarity NPC268917
0.872 High Similarity NPC280653
0.872 High Similarity NPC129106
0.872 High Similarity NPC12875
0.872 High Similarity NPC129784
0.872 High Similarity NPC196765
0.872 High Similarity NPC207892
0.872 High Similarity NPC236014
0.872 High Similarity NPC228369
0.872 High Similarity NPC17343
0.872 High Similarity NPC162801
0.872 High Similarity NPC476166
0.872 High Similarity NPC103799
0.872 High Similarity NPC164574
0.872 High Similarity NPC300875
0.872 High Similarity NPC206224
0.8718 High Similarity NPC33270
0.8718 High Similarity NPC69261
0.8718 High Similarity NPC244816
0.8718 High Similarity NPC474933
0.8718 High Similarity NPC50521
0.8718 High Similarity NPC195466
0.8718 High Similarity NPC221549
0.8707 High Similarity NPC808
0.8684 High Similarity NPC296920
0.8684 High Similarity NPC90520
0.8684 High Similarity NPC255068
0.8678 High Similarity NPC474160
0.8667 High Similarity NPC187868
0.8667 High Similarity NPC212965
0.8667 High Similarity NPC476633
0.8661 High Similarity NPC115335
0.8661 High Similarity NPC225696
0.8661 High Similarity NPC106215
0.8661 High Similarity NPC97834
0.8661 High Similarity NPC198154
0.8661 High Similarity NPC296915
0.8661 High Similarity NPC223008
0.8655 High Similarity NPC247553
0.8651 High Similarity NPC126029
0.8651 High Similarity NPC13005
0.8651 High Similarity NPC78770
0.8651 High Similarity NPC261619
0.8651 High Similarity NPC219876
0.8651 High Similarity NPC185604
0.8651 High Similarity NPC61477
0.8651 High Similarity NPC15658
0.8649 High Similarity NPC8302
0.864 High Similarity NPC32463
0.864 High Similarity NPC470225
0.864 High Similarity NPC27187
0.8629 High Similarity NPC46274
0.8629 High Similarity NPC226331
0.8621 High Similarity NPC22610
0.8621 High Similarity NPC276737
0.8621 High Similarity NPC180508
0.8621 High Similarity NPC228287
0.8621 High Similarity NPC161696
0.8607 High Similarity NPC228503
0.8607 High Similarity NPC138248
0.8596 High Similarity NPC94045
0.8595 High Similarity NPC120638
0.8583 High Similarity NPC215037
0.8583 High Similarity NPC85435
0.8583 High Similarity NPC302107
0.8583 High Similarity NPC218753
0.8583 High Similarity NPC11060
0.8571 High Similarity NPC42760
0.8571 High Similarity NPC137294
0.8571 High Similarity NPC268266
0.8571 High Similarity NPC220825
0.8571 High Similarity NPC181497
0.8571 High Similarity NPC184302
0.8571 High Similarity NPC268342
0.8571 High Similarity NPC85895
0.8571 High Similarity NPC271945
0.8571 High Similarity NPC250727
0.8548 High Similarity NPC250432
0.8548 High Similarity NPC5447
0.8547 High Similarity NPC53906
0.8547 High Similarity NPC167934
0.8537 High Similarity NPC244495
0.8537 High Similarity NPC105718
0.8537 High Similarity NPC476254
0.8537 High Similarity NPC113495
0.8537 High Similarity NPC93219
0.8537 High Similarity NPC278955
0.8537 High Similarity NPC131397
0.8527 High Similarity NPC20829
0.8527 High Similarity NPC262585
0.8527 High Similarity NPC18189
0.8525 High Similarity NPC315807
0.8516 High Similarity NPC117048
0.8516 High Similarity NPC473107
0.8516 High Similarity NPC124085
0.8516 High Similarity NPC476615
0.8516 High Similarity NPC476616
0.8516 High Similarity NPC317380
0.8516 High Similarity NPC476617
0.8509 High Similarity NPC265211
0.8509 High Similarity NPC306045
0.8504 High Similarity NPC86655
0.8504 High Similarity NPC113006
0.8504 High Similarity NPC202762
0.8504 High Similarity NPC307289
0.8492 Intermediate Similarity NPC474481
0.8487 Intermediate Similarity NPC190514
0.8487 Intermediate Similarity NPC96705
0.8468 Intermediate Similarity NPC170485
0.8455 Intermediate Similarity NPC256015
0.8455 Intermediate Similarity NPC228972
0.8455 Intermediate Similarity NPC294156
0.8455 Intermediate Similarity NPC122792
0.845 Intermediate Similarity NPC151224
0.845 Intermediate Similarity NPC474206
0.845 Intermediate Similarity NPC195022
0.845 Intermediate Similarity NPC470356
0.845 Intermediate Similarity NPC473413
0.845 Intermediate Similarity NPC125579
0.845 Intermediate Similarity NPC112246
0.845 Intermediate Similarity NPC15109
0.845 Intermediate Similarity NPC121812
0.845 Intermediate Similarity NPC164787
0.845 Intermediate Similarity NPC61946
0.845 Intermediate Similarity NPC94750

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC74821 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD1548 Phase 1
0.9478 High Similarity NPD1610 Phase 2
0.8934 High Similarity NPD4908 Phase 1
0.8824 High Similarity NPD422 Phase 1
0.879 High Similarity NPD4907 Clinical (unspecified phase)
0.8651 High Similarity NPD1612 Clinical (unspecified phase)
0.8651 High Similarity NPD1613 Approved
0.8629 High Similarity NPD1529 Clinical (unspecified phase)
0.8548 High Similarity NPD1530 Clinical (unspecified phase)
0.8407 Intermediate Similarity NPD968 Approved
0.8346 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8268 Intermediate Similarity NPD4625 Phase 3
0.8258 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8258 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8254 Intermediate Similarity NPD2861 Phase 2
0.8226 Intermediate Similarity NPD4749 Approved
0.8195 Intermediate Similarity NPD1549 Phase 2
0.8106 Intermediate Similarity NPD1510 Phase 2
0.8062 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.8053 Intermediate Similarity NPD940 Approved
0.8053 Intermediate Similarity NPD846 Approved
0.8029 Intermediate Similarity NPD7212 Phase 2
0.8029 Intermediate Similarity NPD7213 Phase 3
0.8017 Intermediate Similarity NPD290 Approved
0.7984 Intermediate Similarity NPD3027 Phase 3
0.7971 Intermediate Similarity NPD7447 Phase 1
0.7965 Intermediate Similarity NPD1242 Phase 1
0.7941 Intermediate Similarity NPD3750 Approved
0.7939 Intermediate Similarity NPD1240 Approved
0.792 Intermediate Similarity NPD1091 Approved
0.7879 Intermediate Similarity NPD5124 Phase 1
0.7879 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7874 Intermediate Similarity NPD3225 Approved
0.7842 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.782 Intermediate Similarity NPD1607 Approved
0.7797 Intermediate Similarity NPD2684 Approved
0.7795 Intermediate Similarity NPD6582 Phase 2
0.7795 Intermediate Similarity NPD6583 Phase 3
0.7778 Intermediate Similarity NPD2796 Approved
0.7778 Intermediate Similarity NPD1551 Phase 2
0.777 Intermediate Similarity NPD1511 Approved
0.7737 Intermediate Similarity NPD1652 Phase 2
0.7686 Intermediate Similarity NPD821 Approved
0.7674 Intermediate Similarity NPD2797 Approved
0.766 Intermediate Similarity NPD1512 Approved
0.7642 Intermediate Similarity NPD6671 Approved
0.7634 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD6516 Phase 2
0.7619 Intermediate Similarity NPD5846 Approved
0.7615 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7615 Intermediate Similarity NPD6584 Phase 3
0.76 Intermediate Similarity NPD1894 Discontinued
0.7589 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD7033 Discontinued
0.7574 Intermediate Similarity NPD3748 Approved
0.7557 Intermediate Similarity NPD3018 Phase 2
0.7541 Intermediate Similarity NPD7843 Approved
0.7541 Intermediate Similarity NPD5535 Approved
0.7522 Intermediate Similarity NPD2933 Approved
0.7522 Intermediate Similarity NPD2934 Approved
0.7519 Intermediate Similarity NPD1296 Phase 2
0.7518 Intermediate Similarity NPD6099 Approved
0.7518 Intermediate Similarity NPD6100 Approved
0.75 Intermediate Similarity NPD1535 Discovery
0.7481 Intermediate Similarity NPD4340 Discontinued
0.7466 Intermediate Similarity NPD1934 Approved
0.7462 Intermediate Similarity NPD8651 Approved
0.7459 Intermediate Similarity NPD228 Approved
0.7456 Intermediate Similarity NPD2860 Approved
0.7456 Intermediate Similarity NPD2859 Approved
0.7448 Intermediate Similarity NPD4380 Phase 2
0.7442 Intermediate Similarity NPD1481 Phase 2
0.7438 Intermediate Similarity NPD5451 Approved
0.7431 Intermediate Similarity NPD1653 Approved
0.7429 Intermediate Similarity NPD7466 Approved
0.7429 Intermediate Similarity NPD3892 Phase 2
0.7415 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7415 Intermediate Similarity NPD2801 Approved
0.741 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD4060 Phase 1
0.7405 Intermediate Similarity NPD1203 Approved
0.7397 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7397 Intermediate Similarity NPD7411 Suspended
0.7395 Intermediate Similarity NPD9697 Approved
0.7394 Intermediate Similarity NPD6799 Approved
0.7388 Intermediate Similarity NPD6798 Discontinued
0.7388 Intermediate Similarity NPD3268 Approved
0.7385 Intermediate Similarity NPD2983 Phase 2
0.7385 Intermediate Similarity NPD2982 Phase 2
0.7385 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD5403 Approved
0.736 Intermediate Similarity NPD7157 Approved
0.736 Intermediate Similarity NPD2557 Approved
0.7357 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7357 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7344 Intermediate Similarity NPD1778 Approved
0.7343 Intermediate Similarity NPD5401 Approved
0.7339 Intermediate Similarity NPD1241 Discontinued
0.7323 Intermediate Similarity NPD1182 Approved
0.7323 Intermediate Similarity NPD6581 Approved
0.7323 Intermediate Similarity NPD6580 Approved
0.7315 Intermediate Similarity NPD7768 Phase 2
0.7308 Intermediate Similarity NPD2981 Phase 2
0.7308 Intermediate Similarity NPD1608 Approved
0.7302 Intermediate Similarity NPD3596 Phase 2
0.7299 Intermediate Similarity NPD3054 Approved
0.7299 Intermediate Similarity NPD3052 Approved
0.7295 Intermediate Similarity NPD4750 Phase 3
0.7279 Intermediate Similarity NPD1558 Phase 1
0.7267 Intermediate Similarity NPD7075 Discontinued
0.7266 Intermediate Similarity NPD6830 Clinical (unspecified phase)
0.7265 Intermediate Similarity NPD3020 Approved
0.7246 Intermediate Similarity NPD4536 Approved
0.7246 Intermediate Similarity NPD2200 Suspended
0.7246 Intermediate Similarity NPD4538 Approved
0.7246 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7231 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.723 Intermediate Similarity NPD6801 Discontinued
0.7218 Intermediate Similarity NPD3690 Phase 2
0.7218 Intermediate Similarity NPD3691 Phase 2
0.7206 Intermediate Similarity NPD6233 Phase 2
0.72 Intermediate Similarity NPD3882 Suspended
0.72 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7194 Intermediate Similarity NPD5960 Phase 3
0.7194 Intermediate Similarity NPD5588 Approved
0.7183 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7183 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD7819 Suspended
0.7176 Intermediate Similarity NPD2235 Phase 2
0.7176 Intermediate Similarity NPD2231 Phase 2
0.7176 Intermediate Similarity NPD1840 Phase 2
0.7164 Intermediate Similarity NPD4993 Discontinued
0.7154 Intermediate Similarity NPD3496 Discontinued
0.7143 Intermediate Similarity NPD3266 Approved
0.7143 Intermediate Similarity NPD3267 Approved
0.7143 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD3817 Phase 2
0.7132 Intermediate Similarity NPD3444 Approved
0.7132 Intermediate Similarity NPD3049 Approved
0.7132 Intermediate Similarity NPD3443 Approved
0.7132 Intermediate Similarity NPD3445 Approved
0.7105 Intermediate Similarity NPD9365 Approved
0.7103 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD6355 Discontinued
0.7095 Intermediate Similarity NPD6599 Discontinued
0.7087 Intermediate Similarity NPD709 Approved
0.7083 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD6666 Approved
0.7083 Intermediate Similarity NPD6667 Approved
0.708 Intermediate Similarity NPD7477 Discontinued
0.7077 Intermediate Similarity NPD17 Approved
0.7077 Intermediate Similarity NPD2556 Approved
0.7077 Intermediate Similarity NPD2554 Approved
0.7071 Intermediate Similarity NPD3846 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD4308 Phase 3
0.7068 Intermediate Similarity NPD6696 Suspended
0.7063 Intermediate Similarity NPD5283 Phase 1
0.7059 Intermediate Similarity NPD6179 Discontinued
0.7059 Intermediate Similarity NPD5163 Phase 2
0.7054 Intermediate Similarity NPD9545 Approved
0.705 Intermediate Similarity NPD1772 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD3134 Approved
0.7045 Intermediate Similarity NPD9717 Approved
0.7039 Intermediate Similarity NPD3749 Approved
0.7029 Intermediate Similarity NPD5837 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD2238 Phase 2
0.7027 Intermediate Similarity NPD111 Approved
0.7023 Intermediate Similarity NPD3847 Discontinued
0.702 Intermediate Similarity NPD4288 Approved
0.702 Intermediate Similarity NPD5402 Approved
0.7007 Intermediate Similarity NPD3056 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD3818 Discontinued
0.7 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6382 Discontinued
0.6993 Remote Similarity NPD1243 Approved
0.6992 Remote Similarity NPD5327 Phase 3
0.6992 Remote Similarity NPD6540 Phase 3
0.6992 Remote Similarity NPD3685 Discontinued
0.6992 Remote Similarity NPD6542 Approved
0.6992 Remote Similarity NPD6543 Approved
0.6992 Remote Similarity NPD1358 Approved
0.6992 Remote Similarity NPD6539 Approved
0.6987 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6987 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6987 Remote Similarity NPD6166 Phase 2
0.6987 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6986 Remote Similarity NPD642 Clinical (unspecified phase)
0.6985 Remote Similarity NPD6832 Phase 2
0.698 Remote Similarity NPD4678 Approved
0.698 Remote Similarity NPD4675 Approved
0.6978 Remote Similarity NPD5735 Approved
0.6972 Remote Similarity NPD3540 Phase 1
0.6966 Remote Similarity NPD5058 Phase 3
0.6966 Remote Similarity NPD6815 Approved
0.6962 Remote Similarity NPD7054 Approved
0.6962 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6957 Remote Similarity NPD4062 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data